Atom | HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)

Funder: National Institutes of Health (NIH)

Due Dates: February 20, 2025 (Letter of Intent) | March 20, 2025 (Application)

Funding Amounts: Up to $300,000 direct costs/year for R61 phase (up to 2 years); up to $750,000 direct costs/year for R33 phase (up to 5 years); total project period up to 6 years.

Summary: Supports translational dissemination and implementation research to reduce overdose deaths, focusing on opioid/stimulant use disorders and pain, via phased R61/R33 awards.

Key Information: Phased award mechanism for projects without preliminary data; requires stakeholder engagement and milestone plans; clinical trial optional.

HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)

Sign in to see full grant listing